convergence_banner_general3_slimmest-01.png
 

PAST AGENDAS:
2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004

The Twitter hashtag for the 2019 event is #CVFORUM19. Request an invite if you are interested in joining us for the 2019 conference.

2019 Agenda

speakers will include:

Ryan Ansin, Co-Founder, Revolutionary Farms
Edward Boyden, PhD, Associate Professor of Media Arts and Sciences and Y. Eva Tan Professor in Neurotechnology, MIT Media Lab and the MIT McGovern Institute
Jay Bradner, MD, Novartis Institute for Biomedical Research
Pablo Cagnoni, MD, CEO, Rubius Therapeutics
Michael Cloonan, Chief Business Officer, Sage Therapeutics
Ann Dewitt, PhD, General Partner, The Engine, MIT
Sandro Galea, MD, MPH, DrPH, Dean and Robert A. Knox Professor, Boston University School of Public Health
Paulo Garcia, PhD, Co-Founder and CEO, Kytopen
Jason Gardner, PhD, CEO, Magenta Therapeutics
Jamie Heywood, Co-Founder & Chief Research Officer, iCarbonX
John Maraganore, PhD, CEO, Alnylam Pharmaceuticals
Eddie Martucci, Co-Founder and CEO, Akili Interactive Labs
Corey McCann, MD, PhD, Founder and CEO, Pear Therapeutics
David Meeker, MD, CEO, KSQ Therapeutics
Jimmy Rosen, CEO, Artisan Biosciences
Nabiha Saklayen, PhD, Co-founder and CEO, Cellino Biotech
Kazumi Shiosaki, PhD, Managing Director, Executive Partner, MPM and founding CEO of Twentyeight-Seven
Dan Skrovronsky, MD, PhD, Senior Vice President and Chief Scientific Officer, Eli Lilly and Company
Paula Skrovronsky, CEO, Akcea Therapeutics
Joris Van Dam, Executive Director, Head of Digital Therapeutics, Novartis Institutes for BioMedical Research (NIBR)